Profile data is unavailable for this security.
About the company
Hangzhou Biotest Biotech Co Ltd is a company mainly engaged in the research and development (R&D), production and sales of point-of-care testing (POCT) diagnostic reagents. The Company's products include reproductive health testing series, such as human chorionic gonadotropin testing reagent and luteinizing hormone testing reagent, and drug abuse testing series, such as morphine testing reagent and cocaine testing reagent, and infectious disease testing series, such as adenovirus testing reagent and typhoid antibody testing reagent, and tumor marker testing series, such as alpha fetoprotein detection reagent, and myocardial marker detection series, such as dimer detection reagent and myocardial series detection reagent.
- Revenue in CNY (TTM)474.05m
- Net income in CNY134.34m
- Incorporated2008
- Employees629.00
- LocationHangzhou Biotest Biotech Co LtdNo. 27, Tuyi RoadCangqian Neighborhood, Yuhang DistrictHANGZHOU 311100ChinaCHN
- Phone+86 57 189058091
- Fax+86 57 189058091
- Websitehttp://www.biotests.com.cn/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beijing Hotgen Biotech Co Ltd | 454.44m | -26.45m | 2.32bn | 1.04k | -- | 0.6838 | -- | 5.10 | -0.3093 | -0.3093 | 5.14 | 36.65 | 0.1264 | 1.64 | 6.32 | 438,645.70 | -1.04 | 29.65 | -1.11 | 34.70 | 50.71 | 56.08 | -8.25 | 32.26 | 5.50 | -- | 0.0027 | 41.92 | -84.78 | 23.67 | -97.10 | -10.67 | 57.98 | -- |
Nanjing Vishee Medical Technology Co Ltd | 454.35m | 127.93m | 2.39bn | 700.00 | 18.60 | 1.44 | -- | 5.25 | 1.34 | 1.34 | 4.76 | 17.29 | 0.2583 | 3.38 | 15.91 | 649,077.10 | 7.27 | 10.27 | 7.85 | 11.43 | 70.28 | 73.26 | 28.16 | 33.99 | 10.18 | -- | 0.00 | 47.57 | 43.72 | 17.34 | 45.22 | 16.55 | 26.69 | -- |
Chemclin Diagnostics Co Ltd | 455.80m | 150.93m | 2.39bn | 731.00 | 15.84 | 1.73 | -- | 5.24 | 0.3764 | 0.3764 | 1.14 | 3.45 | 0.2684 | 1.02 | 17.03 | 623,526.50 | 8.89 | 11.01 | 9.82 | 12.32 | 74.73 | 74.19 | 33.11 | 31.07 | 5.09 | -- | 0.1518 | 36.64 | -4.28 | 4.00 | -3.44 | -- | 44.10 | -- |
Jinan High-tech Development Co Ltd | 555.10m | -119.73m | 2.55bn | 716.00 | -- | 13.08 | -- | 4.59 | -0.1353 | -0.1353 | 0.6275 | 0.2201 | 0.1874 | 0.6198 | 0.6935 | 775,274.40 | -4.46 | -2.99 | -22.92 | -9.42 | 15.19 | 30.52 | -23.79 | -10.84 | 0.5687 | -- | 0.4146 | -- | -58.29 | -13.80 | -618.17 | -- | -35.45 | -- |
Hangzhou Biotest Biotech Co Ltd | 474.05m | 134.34m | 2.58bn | 629.00 | 19.07 | 1.05 | -- | 5.45 | 1.27 | 1.27 | 4.48 | 23.08 | 0.1788 | 2.17 | 8.38 | 753,658.60 | 5.03 | 29.45 | 5.32 | 33.30 | 49.40 | 56.83 | 28.13 | 41.59 | 13.02 | -- | 0.0009 | 29.32 | -76.75 | 19.65 | -86.22 | 41.33 | 34.82 | -- |
Shanghai Kindly Enterprise Dev Gp Co Ltd | 2.34bn | 206.32m | 2.63bn | 4.23k | 12.61 | 1.06 | -- | 1.13 | 0.4734 | 0.4734 | 5.36 | 5.62 | 0.5595 | 3.80 | 2.35 | 552,556.30 | 5.74 | 8.09 | 9.36 | 16.09 | 30.50 | 36.01 | 10.27 | 12.53 | 1.26 | -- | 0.2248 | 26.55 | -21.36 | 11.08 | -25.92 | 9.44 | 4.85 | 1.30 |
Shanghai ZJ Bio-Tech Co Ltd | 241.21m | -115.98m | 2.69bn | 305.00 | -- | 0.7003 | -- | 11.14 | -0.6425 | -0.6425 | 1.26 | 19.98 | 0.0563 | 0.2057 | 1.59 | 790,860.40 | -2.71 | 17.08 | -2.87 | 19.18 | 67.55 | 60.21 | -48.08 | 34.13 | 14.96 | -- | 0.0016 | 34.15 | -88.21 | 4.10 | -118.00 | -- | 35.93 | -- |
Goodwill E-Health Info Co Ltd | 710.23m | 53.31m | 2.75bn | 2.05k | 51.85 | 1.51 | -- | 3.87 | 0.3825 | 0.3825 | 5.12 | 13.11 | 0.2786 | 0.5932 | 0.9636 | 346,453.70 | 1.40 | 1.28 | 1.94 | 1.95 | 51.15 | 50.60 | 5.02 | 3.48 | 1.86 | -- | 0.1409 | 0.00 | -3.04 | 22.09 | -37.53 | -- | 66.10 | -- |
Shanghai General Hthy Info & Tech Co Ltd | 281.92m | 55.30m | 2.79bn | 355.00 | 50.39 | 2.63 | -- | 9.88 | 0.4066 | 0.4066 | 2.07 | 7.78 | 0.2244 | 1.30 | 0.8219 | 794,132.60 | 4.46 | 11.22 | 5.39 | 14.13 | 60.04 | 53.64 | 19.89 | 30.54 | 3.88 | -- | 0.052 | 14.00 | -4.59 | 3.70 | -48.13 | -4.27 | 9.32 | -- |
Holder | Shares | % Held |
---|---|---|
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 2.74m | 6.90% |
Maxwealth Fund Management Co., Ltd.as of 31 Dec 2023 | 142.43k | 0.36% |
Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 138.42k | 0.35% |
Tian Hong Asset Management Co., Ltd.as of 31 Dec 2023 | 115.44k | 0.29% |
Golden Trust Sinopac Fund Management Co., Ltd.as of 31 Dec 2023 | 101.35k | 0.26% |
Huatai-PineBridge Fund Management Co., Ltd.as of 31 Dec 2023 | 53.96k | 0.14% |
E Fund Management Co., Ltd.as of 31 Dec 2023 | 39.30k | 0.10% |
Fuanda Fund Management Co., Ltd.as of 31 Dec 2023 | 17.72k | 0.05% |
Jyah Asset Management Co. Ltd.as of 31 Dec 2023 | 10.99k | 0.03% |
China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 10.11k | 0.03% |